New targeted therapy shows promising early results in advanced pancreatic cancer

Дата публикации: 05-07-2026 13:20:03

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown promising early results when combined with standard first-line chemotherapy, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer	5	7	02-07-2026
2	Investigators report promising results from Phase II trial of targeted therapy for rare bile duct cancer	7	8	01-07-2026
3	EMA Recommends Extension of Therapeutic Indications for Enfortumab Vedotin	0	5	19-06-2026
4	EMA Recommends Extension of Therapeutic Indications for Encorafenib	0	5	03-07-2026
5	Blood test may help identify which colorectal cancer patients most likely to benefit from chemotherapy after surgery	0	5	06-07-2026
6	EMA Recommends Extension of Therapeutic Indications for Sacituzumab Govitecan	0	5	10-07-2026
7	Blood Test May Help Identify Which Colorectal Cancer Patients with Liver Metastases Are Most Likely to Benefit from Chemotherapy After Surgery	0	7	03-07-2026
8	Blood test finds hidden pancreatic cancer after treatment	5	8	30-06-2026
9	Oral Sunvozertinib Prolongs PFS Over Chemotherapy as First-Line Treatment for Patients with Advanced NSCLC with EGFR Exon 20 Insertions	0	5	23-06-2026
10	Novel biomarker research offers new hope in the fight against colorectal cancer	7	8	06-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 2. Информативность: 7. Источник: medicalxpress.com.